Hohneker John 4

What Happened
John Hohneker, a director of Curis, was granted a derivative award on July 7, 2026 that covers 6,800 shares at an exercise/acquisition price of $5.29 per share, with a total notional value of $35,972. This filing reports an award/acquisition (derivative) rather than an open-market purchase or sale.

Key Details

• Transaction date: July 7, 2026; Form 4 filed July 9, 2026 (Accession: 0001108205-26-000094).
• Instrument: Derivative award/option-style grant for 6,800 underlying shares.
• Price: $5.29 per share; total value shown $35,972 (based on that price × shares).
• Vesting: Footnote states the option grant vests 100% on July 7, 2027.
• Shares owned after transaction: Not specified in the provided filing summary.
• Filing remarks: Exhibit 24.1 (Power of Attorney) included.

Context
This is a compensation-related derivative grant (an option/award that confers the right to acquire shares in the future when vested), not an immediate buy or sale of stock. Such grants are common for directors and are intended as long-term incentive compensation; they don’t by themselves indicate an immediate market position change. The vesting schedule means the award becomes exercisable/owned only after July 7, 2027, subject to any plan terms.